PRIMARY STUDY

Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies

Key Findings:  Inconsistent evidence leans in favor of CBD being able to reduce positive symptoms, but not negative symptoms. Similarly, inconsistent evidence leans in favor of CBD being able to improve cognition. When examining the adverse effects potential of CBD results suggest sedation in one study while other studies indicated good tolerability, even at higher dosages.